ArticleBMJ open2019

Prospective multicentre open-label randomised controlled trial of 3-month versus 12-month dual antiplatelet therapy after implantation of the new generation biodegradable polymer sirolimus TARGET-eluting coronary stent: protocol of the TARGET DAPT trial.

Hongbo Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.